Literature DB >> 1279002

Relationship of the cell wall composition of group H streptococci and Streptococcus sanguis to their serological properties.

B Rosan.   

Abstract

Previous studies indicated the a antigen was widely distributed among strains of Streptococcus sanguis and the group H streptococci. The cell walls of strains containing this antigen had moderate to large quantities of rhamnose, small amounts of phosphorus, and little to no ribitol. The molar ratios of the peptidoglycan amino acids and hexosamines suggested a di-alanyl cross bridge. The homogeneity of the walls of these strains suggested that serological group H can be considered synonymous with S. sanguis. In contrast those strains that did not contain the a antigen had only small amounts of rhamnose in their cell walls, galactosamine and ribitol were always detected, and large quantitites of phosphorus were present. The molar ratios of peptidoglycan components in the latter strains suggested a direct alanyl-lysl cross bridge. Although many of these strains had been classified either as S. sanguis or group H streptococci because of minor serological cross-reactions and similar biochemical properties, the distinct differences between the composition of their cell walls and those of S. sanguis and group H streptococci indicate that they do not belong in this species or group. The cell walls of strains containing the a antigen are relatively homogeneous and therefore it is suggested that cells containing this antigen be considered Lancefield serological group H.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1279002      PMCID: PMC420731          DOI: 10.1128/iai.13.4.1144-1153.1976

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  The chemical composition of pneumococcal C-polysaccharide.

Authors:  T Y LIU; E C GOTSCHLICH
Journal:  J Biol Chem       Date:  1963-06       Impact factor: 5.157

2.  The chemical composition of the cell wall in some gram-positive bacteria and its possible value as a taxonomic character.

Authors:  C S CUMMINS; H HARRIS
Journal:  J Gen Microbiol       Date:  1956-07

3.  Attributes of potential utility in differentiating among "group H" streptococci or Streptococcus sanguis.

Authors:  R M Cole; G B Calandra; E Huff; K M Nugent
Journal:  J Dent Res       Date:  1976-01       Impact factor: 6.116

4.  A modification of the Park and Johnson reducing sugar determination suitable for the assay of insoluble materials: its application to bacterial cell walls.

Authors:  J S Thompson; G D Shockman
Journal:  Anal Biochem       Date:  1968-02       Impact factor: 3.365

5.  Identification and quantitation of alditol acetates of neutral and amino sugars from mucins by automated gas-liquid chromatography.

Authors:  L J Griggs; A Post; E R White; J A Finkelstein; W E Moeckel; K G Holden; J E Zarembo; J A Weisbach
Journal:  Anal Biochem       Date:  1971-10       Impact factor: 3.365

6.  Streptococcus sanguis: a model in the application in immunochemical analysis for the in situ localization of bacteria in dental plaque.

Authors:  B Rosan; C H Lai; M A Listgarten
Journal:  J Dent Res       Date:  1976-01       Impact factor: 6.116

7.  Structure of the peptidoglycan from vegetative cell walls of Bacillus subtilis.

Authors:  A D Warth; J L Strominger
Journal:  Biochemistry       Date:  1971-11-23       Impact factor: 3.162

8.  The cell walls of streptococci.

Authors:  G Colman; R E Williams
Journal:  J Gen Microbiol       Date:  1965-12

9.  Peptidoglycan composition and taxonomy of group D, E, and H streptococci, and Streptococcus mutans.

Authors:  H D Slade; W C Slamp
Journal:  J Bacteriol       Date:  1972-02       Impact factor: 3.490

10.  Antigens of Streptococcus sanguis.

Authors:  B Rosan
Journal:  Infect Immun       Date:  1973-02       Impact factor: 3.441

View more
  24 in total

1.  Role of sialic acid in saliva-induced aggregation of Streptococcus sanguis.

Authors:  B C McBride; M T Gisslow
Journal:  Infect Immun       Date:  1977-10       Impact factor: 3.441

2.  Purification and immunochemical characterization of Streptococcus sanguis serotype I carbohydrate antigen.

Authors:  N Okahashi; T Koga; H Akada; S Hamada
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

3.  Antigens of Streptococcus sanguis: purification and characterization of the b antigen.

Authors:  B Appelbaum; B Rosan
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

4.  Nutritionally variant streptococci from patients with endocarditis: growth parameters in a semisynthetic medium and demonstration of a chromophore.

Authors:  A Bouvet; I van de Rijn; M McCarty
Journal:  J Bacteriol       Date:  1981-06       Impact factor: 3.490

5.  In vitro studies of dental plaque formation: adsorption of oral streptococci to hydroxyaptite.

Authors:  B Appelbaum; E Golub; S C Holt; B Rosan
Journal:  Infect Immun       Date:  1979-08       Impact factor: 3.441

6.  Identification of a Streptococcus salivarius cell wall component mediating coaggregation with Veillonella alcalescens V1.

Authors:  A H Weerkamp; B C McBride
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

7.  Identification and preliminary characterization of a Streptococcus sanguis fibrillar glycoprotein.

Authors:  E J Morris; N Ganeshkumar; M Song; B C McBride
Journal:  J Bacteriol       Date:  1987-01       Impact factor: 3.490

8.  Optimization of an hydroxyapatite adhesion assay for Streptococcus sanguis.

Authors:  R Eifert; B Rosan; E Golub
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

9.  Characterization of an amylase-binding component of Streptococcus gordonii G9B.

Authors:  F A Scannapieco; G G Haraszthy; M I Cho; M J Levine
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

10.  Production of lipoteichoic acid by lactobacilli and streptococci grown in different environments.

Authors:  A J Wicken; K W Broady; A Ayres; K W Knox
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.